
CSL acquires majority stake in Chinese plasma manufacturer Ruide for $352mm, plus earn-out
Executive Summary
Deal Industry
- Pharmaceuticals
- Services
-
Biotechnology
- Synthesis Technologies, Production Processes
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Includes Earnout
- Partial Acquisition
- Payment Includes Cash
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com